There has been some interesting happenings around the world about declining FDA approved drugs in other countries. I'm just adding this to the ever growing information regarding FDA we have gathered. As a reminder......Some countries will actually make decisions on their own about drugs.
July 23, 2021 09:49 AM EDT Pharma
EMA rejects FDA-approved Parkinson's drug, signs off on Moderna vaccine use in adolescents ahead of FDA
https://endpts.com/ema-rejects-fda-approved-parkinsons-drug-signs-off-on-moderna-vaccine-use-in-adolescents-ahead-of-fda/
The European Medicines Agency on Friday rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant (istradefylline), which the US FDA approved in 2019 under the brand name Nourianz.
EMA said it considered that the results of the clinical studies used to support the application “were inconsistent and did not satisfactorily show that Nouryant was effective at reducing the ‘off’ time. Only four out of the eight studies showed a reduction in ‘off’ time, and the effect did not increase with an increased dose of Nouryant.”
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-1845
-
- There are more pages in this discussion • 2,604 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $72.61M |
Open | High | Low | Value | Volume |
20.0¢ | 21.0¢ | 20.0¢ | $74.00K | 361.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 107874 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 177615 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 107984 | 0.205 |
24 | 653358 | 0.200 |
19 | 571066 | 0.195 |
19 | 637069 | 0.190 |
10 | 197200 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 177615 | 9 |
0.215 | 125958 | 5 |
0.220 | 147666 | 4 |
0.225 | 250000 | 1 |
0.230 | 289296 | 5 |
Last trade - 13.50pm 01/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |